FDA Panel Rejects OTC Use of Montelukast (Singulair Allergy)FDA Panel Rejects OTC Use of Montelukast (Singulair Allergy)

The FDA advisory committee has recommended against use of partial expansion of montelukast for OTC use against allergic rhinitis. Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news

Related Links:

A consistent increase in the intensity and length of allergy season in regions of the United States signals a difficult season in 2020, at the same time as the COVID-19 pandemic affects communities.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
‘Grandfather of allergy’ survived three years in Japanese POW camp before pioneering medical careerDr William Frankland, a pioneering British immunologist who transformed the world ’s understanding of allergies, has died aged 108.Frankland improved the lives of millions of hay fever sufferers by developing the idea of apollen count. Until his death the oldest survivor of the Japanese prisoner of war camps, he published a scientific paper in September 2017 aged 105.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Immunology Biochemistry and molecular biology Medical research Science UK news Hay fever Allergies Source Type: news
The aim was to determine the level of inflammatory cytokines, eosinophil cationic protein and IgE in allergic rhinitis (AR) patients.
Source: Clinical and Molecular Allergy - Category: Allergy & Immunology Authors: Tags: Research Source Type: research
In his long career, Dr. Frankland helped legions of hay fever sneezers by publicizing pollen counts. Among his many patients was Saddam Hussein.
Source: NYT Health - Category: Consumer Health News Authors: Tags: William Frankland Great Britain Deaths (Obituaries) Allergies Pollen Research Source Type: news
Authors: Degirmenci N, Dogan R, Tugrul S, Senturk E, Toprak A, Ozturan O Abstract OBJECTIVE: To evaluate the colour values of nasal mucosa for the purpose of presenting an objective parameter of allergic rhinitis. METHODS: Seventy-three patients with allergic rhinitis (allergy group) and 73 normal healthy individuals (control group) were included in the study. Endoscopic examinations were conducted, and endoscopic photographs of the septum and both inferior turbinates were taken. The Adobe Photoshop Elements 7.0 software program was used to measure the numerical values of red-green-blue (RGB) colour components ...
Source: Journal of Laryngology and Otology - Category: ENT & OMF Tags: J Laryngol Otol Source Type: research
This study was designed to identify the effect of different first prescription lengths on the adherence to SLIT.MethodsThe clinical data of 306 patients with AR who started SLIT between January 2017 and June 2018 were retrospectively reviewed. Patients were divided into 3 groups according to the length of their first prescription (group A: less than 3 months, group B: 3 to 6 months, group C: more than 6 months). The numbers of adherent or nonadherent patients in each group and the main reasons of nonadherence were analyzed.ResultsGroups A, B, and C included 102, 161, and 43 patients, respectively. The average lengths of th...
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: ORIGINAL ARTICLE Source Type: research
(HAMBURG, Pa.) — The spring breezes of 2020 are carrying more than just tree pollen. There’s a whiff of paranoia in the air. For millions of seasonal allergy sufferers, the annual onset of watery eyes and scratchy throats is bumping up against the global spread of a new virus that produces its own constellation of respiratory symptoms. Forecasters are predicting a brutal spring allergy season for swaths of the U.S. at the same time that COVID-19 cases are rising dramatically. That’s causing angst for people who never have had to particularly worry about their hay fever, other than to stock up on antihista...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 News Desk wire Source Type: news
CONCLUSIONS: TRI, as an active immunoregulatory factor, has great potential in the treatment of mast cell-mediated allergic diseases. PMID: 32216736 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Biotechnology - Category: Biotechnology Authors: Tags: Curr Pharm Biotechnol Source Type: research
Polymorphism -509C/T in TGFB1 Promoter Is Associated With Increased Risk and Severity of Persistent Allergic Rhinitis in a Chinese Population. Am J Rhinol Allergy. 2020 Mar 26;:1945892420913441 Authors: Zhu XJ, Lu MP, Chen RX, Bu DY, Zhu LP, Wang ML, Yin M, Zhang ZD, Cheng L PMID: 32216462 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - Category: ENT & OMF Authors: Tags: Am J Rhinol Allergy Source Type: research
PMID: 32208746 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - Category: ENT & OMF Authors: Tags: Am J Rhinol Allergy Source Type: research
More News: Allergy | Allergy & Immunology | Hay Fever | Singulair